Skip to main content
Have a personal or library account? Click to login
Clinical and Electrophysiological Heterogeneity of Orthostatic Tremor: An Individual Patient Data Analysis Cover

Clinical and Electrophysiological Heterogeneity of Orthostatic Tremor: An Individual Patient Data Analysis

Open Access
|Oct 2026

Full Article

Introduction

Orthostatic tremor (OT), also known as “shaky legs syndrome,” was first described as a distinct entity by Heilman [1], although similar cases had been reported previously [2]. OT is characterized by unsteadiness and leg shaking while standing, with symptoms typically improving after sitting or walking [3]. Although the legs are predominantly involved, upper-limb, truncal, and facial muscle involvement has also been reported. Compared with more common tremor syndromes, such as essential tremor, OT remains rare [4, 5].

The diagnosis of OT requires electrophysiological confirmation with electromyography (EMG) [6]. Historically, a standing tremor frequency of 13–18 Hz was considered essential for diagnosis [7]. Using this criterion, Gerschlager et al. [8] divided OT into two categories: primary OT and OT plus, the latter referring to OT associated with other neurological conditions. Several alternative classification schemes have subsequently been proposed, including distinctions based on tremor frequency (slow, intermediate, and classical OT) and association with neurological disorders, reflecting uncertainty regarding the optimal framework. [9, 10, 11].

The 2018 consensus statement of the International Parkinson and Movement Disorder Society (MDS) classified tremor syndromes along two axes: Axis 1, based on clinical features, and Axis 2, based on etiology. Within this framework, OT was classified as primary orthostatic tremor (13–18 Hz and isolated), primary orthostatic tremor plus (13–18 Hz with additional neurological signs), or pseudo-orthostatic tremor (<13 Hz, often associated with other neurological conditions) [6].

Despite these classification systems, several limitations remain. Primary OT is defined by a 13–18 Hz frequency range, yet cases with frequencies above 18 Hz have also been reported [12, 13, 14, 15]. Frequency may also fluctuate over time or within the same recording, making classification dependent on the timing and duration of measurement [9]. Overlap between intermediate (10–13 Hz) and classical frequency ranges further blurs subtype distinctions [16]. Additionally, isolated cases in the intermediate range appear to share more features with primary (classical) OT (≥13 Hz) than with other slow tremor syndromes [17, 18]. In addition, the distinction between primary OT, OT-plus, and pseudo-orthostatic tremor may not always be straightforward, with associated non-neurological conditions not represented. The current classification also may not adequately account for this possible longitudinal progression, where isolated presentations may progress to more complex or secondary forms over time [19].

Given these limitations, it remains uncertain whether current classification frameworks fully capture the clinical heterogeneity of OT. In particular, rigid frequency thresholds and a binary distinction between primary OT and OT-plus may not adequately reflect cases with fluctuating or boundary-spanning frequencies or non-neurological systemic associations. Hence, there is a need to evaluate whether frequency-based and etiological classifications adequately reflect the observed clinical heterogeneity in published cases of OT. The present review therefore evaluates the relationships between tremor frequency, associated conditions, and clinical parameters to better characterize the clinical and electrophysiological heterogeneity through a systematic review of published case reports. We hypothesize that orthostatic tremor represents a heterogeneous disorder and that its clinical expression is better captured through an integrated framework incorporating clinical phenotype and frequency variability.

Methods

This systematic review was conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines.

Search Strategy

A comprehensive search of PubMed/MEDLINE was conducted from database inception through February, 2026. The search string used was: (“orthostatic tremor”) OR (“shaky leg syndrome”) OR (“shaky legs syndrome”) OR (“slow orthostatic tremor”) OR (“pseudo-orthostatic tremor”) OR (“orthostatic tremor plus”) OR (“secondary orthostatic tremor”).

Selection Criteria

We included case reports, case series, and original studies that provided individual patient data for patients with EMG-confirmed OT, defined as rhythmic lower-limb muscle activity occurring during standing. Outcomes of interest included demographic data, OT frequency, and other associated conditions/disorders at presentation. Studies were excluded if they did not provide individual patient data or did not report or measure OT frequency. Orthostatic myoclonus cases were excluded.

Data Extraction

Two reviewers independently screened the titles and abstracts of all identified articles after deduplication. Full-text articles of potentially relevant studies were retrieved and assessed for eligibility. Each case was classified according to the MDS OT classification [6]. In addition, cases were operationally classified as isolated or non-isolated based on associated conditions at presentation. This study grouping was used for analysis and was not intended to establish causality. When frequency was reported as a range for a single patient, the average of the range was taken for analysis.

Statistical Analysis

Statistical analyses were performed using IBM SPSS Statistics, version 22.0 (IBM Corp., Armonk, NY, USA). Normality was assessed by visual inspection of histograms and Shapiro-Wilk tests. Continuous variables are presented as mean (SD), and categorical variables are summarized as frequencies and percentages. Receiver operating characteristic (ROC) analysis was used to evaluate the ability of tremor frequency to distinguish isolated from non-isolated OT presentations. The Youden index was calculated to determine the optimal frequency threshold. Spearman’s correlations, Chi-square and Mann-Whitney U tests were used to assess associations between variables. A p value < 0.05 was considered statistically significant.

Results

Cohort characteristics and clinical Profile

A total of 100 articles fulfilled the inclusion criteria and were included in the analysis (Figure 1), comprising 244 patients (Supplementary table 1 and References [9, 10, 12, 13, 14, 15, 17, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99, 100, 101, 102, 103, 104, 105, 106, 107, 108, 109, 110, 111, 112]). The cohort had a mean age of 62.61 ± 13.43 years. Age ranged from 7 to 86 years. A female predominance was observed with 96 male patients and 148 female patients. A positive family history of OT was present in 17 patients. Mean disease duration among cases which reported the same (n = 222) was 7.83 ± 6.72 years.

Figure 1

PRISMA flowchart.

Frequency distribution

The mean tremor frequency across all cases was 13.32 ± 4.15 Hz, with a range of 3–20 Hz (Figure 2). According to the current MDS classification, we grouped 127 patients as having primary OT. 39 had OT plus, and 61 had pseudo-orthostatic tremor. 17 cases could not be definitively classified within the existing framework: 12 showed frequency fluctuations across the 13-Hz threshold, and five exceeded the upper frequency limit of 18 Hz (Table 1). Using our operational clinical grouping, 148 patients were classified as having isolated OT and 96 as having non-isolated presentations (Table 2).

Figure 2

Density plots of tremor frequency for isolated (blue) and non-isolated (orange) OT.

Table 1

Clinical spectrum of OT cases according to the MDS classification.

PARAMETERPRIMARY OTOT PLUSPSEUDO OTUNCLASSIFIABLE (FLUCTUATING FREQUENCY)UNCLASSIFIABLE (>18 Hz)
N1273961125
Age (SD)64.13 (11.25)64.41(13.55)58.56 (16.03)61.67 (17.48)61.80 (13.05)
Sex (M/F)50/7714/2525/364/83/2
Mean Tremor Frequency in Hz (SD)15.58 (1.26)15.46 (1.41)6.82 (2.36)13.12 (1.17)18.92 (0.71)
Familial history of OT132200
Table 2

Clinical spectrum of OT cases based on isolated/non-isolated phenotype.

PARAMETERISOLATED OTNON-ISOLATED OT
N14896
Age (SD)63.97 (11.35)60.51 (15.96)
Sex (M/F)60/8836/60
Mean Tremor Frequency in Hz (SD)14.80 (2.82)11.03 (4.81)
≥13 Hz/<13 Hz129/1949/47
Familial history of OT125

Patients with non-isolated OT had significantly lower tremor frequencies compared to those with isolated OT (11.03 Hz vs. 14.80 Hz, p < 0.001). In contrast, age and sex were not associated with tremor frequency or phenotype. A positive correlation was observed between tremor frequency and reported disease duration (Spearman’s ρ = 0.366, p < 0.001).

Receiver operating characteristic analysis showed that tremor frequency had the discriminatory ability to distinguish isolated from non-isolated OT (AUC = 0.72, p < 0.001, 95% CI, 0.60–0.85). The optimal frequency threshold identified using the Youden index was 10 Hz with a sensitivity of 45% and specificity of 93%.

To determine whether tremor frequency independently predicted clinical phenotype, a multivariable logistic regression model was constructed with non-isolated OT as the dependent variable and age, sex, disease duration, and tremor frequency as covariates. Tremor frequency was the only independent predictor with frequency inversely associated with non-isolated orthostatic tremor (OR = 0.78, 95% CI 0.71–0.85, p < 0.001), whereas age, sex, and disease duration were not significant predictors (Nagelkerke R2 = 0.27).

Conditions associated with OT

Parkinsonism and related disorders were most commonly associated with OT (n = 38). This was followed by essential tremor, cerebellar disorders and lesions, and unilateral brainstem lesions (midbrain and pons). Non-neurological disorders such as hyperthyroidism and musculoskeletal injury (knee injury) were also associated with OT. The frequency distribution of OT associated with other conditions is presented in Table 3.

Table 3

Disorders associated with OT.

ASSOCIATED DISORDERSTOTAL NUMBER<13 Hz N (%)≥13 Hz N (%)MEAN TREMOR FREQUENCYSDMINIMUM FREQUENCYMAXIMUM FREQUENCY
Parkinson’s disease/Parkinsonism/PSP3822 (57.9)16 (42.1)10.075.171318
Essential tremor103 (30)7 (70)13.503.7526.519
Cerebellar disorders/lesions102 (20.0)8 (80.0)12.733.3824.515
Brainstem lesions62 (33.3)4 (66.7)12.375.2584.2517.5
Hyperthyroid states53 (60.0)2 (40.0)10.504.213615
Musculoskeletal injury21 (50)1 (50)10.757.4255.516
Hereditary spastic paraplegia31 (33.3)2 (66.7)14.004.583918
Stiff person syndrome20 (0.0)2 (100.0)16.000.0001616
Dementia20 (0.0)2 (100.0)15.002.8281317
Miscellaneous1813 (72.2)5 (27.8)8.984.5023.516
Isolated OT14819 (12.8)129 (87.2)14.802.8213.520

Discussion

OT has long occupied an uncertain position within the broader landscape of tremor disorders, initially regarded as a rare and relatively homogeneous condition [1, 3]. This review, which synthesizes published individual cases across the clinical spectrum of OT, suggests that the disorder is more heterogeneous than previously thought.

Although the pathophysiology of OT remains incompletely understood, the disorder is widely thought to involve a pathologically active oscillator within the cerebello-thalamo-cortical network [39, 113]. Functional imaging and connectivity studies have demonstrated abnormal coupling within lateral cerebellar and supplementary motor area networks in patients with OT, implicating a distributed network rather than a single anatomical node as the likely substrate of rhythmic tremor generation [113]. The ventralis intermedius nucleus of the thalamus occupies a critical position within this circuit, and the therapeutic efficacy of Ventralis intermedius nucleus deep brain stimulation supports its relevance to OT oscillations [52, 68].

Our cohort was broadly representative of the OT population described in the literature: predominantly middle-aged to older adults with a female preponderance [3]. However, a meaningful subset of patients could not be assigned to existing categories without ambiguity. Two patterns of nonconformity emerged. In one group, tremor frequency fluctuated considerably across the 13-Hz boundary used to distinguish primary OT from lower-frequency variants, making single-point classification dependent on when the recording was obtained. In a smaller group, tremor frequencies exceeded the upper 18-Hz limit, for which the current criteria designates no formal category.

The finding that some patients fluctuate across the 13-Hz boundary is consistent with a dynamic oscillator model and has precedent in the tremor literature [114, 115]. Thompson et al. provided early electrophysiological documentation of patients with primary OT at 14–16 Hz who exhibited intermittent oscillatory episodes at approximately half that frequency [9]. They noted that the primary 16-Hz tremor appeared as a fine ripple beneath the skin because of partial fusion of muscle contractions, whereas the 8-Hz subharmonic produced a more clinically apparent oscillation and worsened the patient’s subjective unsteadiness. Although the mechanism was uncertain, the overall 16-Hz frequency supported a central rather than peripheral origin. The authors proposed that the tremor arose from abnormal feed-forward postural signals required for standing, implicating central oscillatory structures such as the inferior olive or thalamus. Subsequent reports have reinforced the clinical relevance of an 8-Hz subharmonic arising from a 16-Hz primary oscillator, suggesting that subharmonic states may have functional consequences rather than representing electrophysiological artifacts [115]. Multimode oscillatory behaviour is not unique to OT. In Parkinsonian and essential tremor, simultaneous recordings have shown coherent activity at both the tremor frequency and its harmonic, indicating that harmonic and subharmonic modes can operate within the same network [116, 117].

Density plots of tremor frequency (Figure 2) showed a bimodal distribution of frequencies for the non-isolated group. The lower and higher frequency clusters of non-isolated OT observed from the plot did not differ distinctly in the spectrum of OT-associated etiologies. However, this does raise the question of why frequencies cluster in a bimodal distribution and whether the two clusters differ in tremor phenomenology. Further studies are needed to validate and explain the same. On the other hand, the majority of the isolated OT patients were found in the ≥13 Hz range. We found that among these patients with isolated OT, those with tremor frequency below 13 Hz had a lower average age than those with higher frequencies (58.78 vs 64.73 years). This raises the possibility that isolated sub-13-Hz OT, in some patients, may represent an early manifestation of neurodegenerative disorders such as Parkinson’s disease, with patients initially presenting with isolated OT before later developing symptoms of neurodegenerative disease, and hence, a non-isolated phenotype with time. Although our study design prevents us from making definitive conclusions, previous studies support this hypothesis. Ganos et al. reported that seven isolated OT cases subsequently developed additional neurological signs, including one patient who developed Parkinson’s disease [19]. In another case series, four patients with sub-13-Hz OT later developed parkinsonism, and all had a marked response to levodopa [10]. We also observed a positive correlation between tremor frequency and disease duration, which potentially may suggest that tremor frequency evolves with disease. Because disease duration and tremor frequency were assessed cross-sectionally, this association should be interpreted carefully.

Although tremor frequency independently distinguished isolated from non-isolated OT, its discriminatory performance was limited. These findings indicate that while tremor frequency is a significant electrophysiological marker, it may be insufficient as a standalone classifier of clinical phenotype. Furthermore, the data-driven exploratory threshold (≈ 10 Hz) differed from the conventional 13 Hz boundary, and approximately 6.97% of EMG-confirmed patients remained unclassifiable using the existing frequency-based criteria. These findings suggest that while tremor frequency remains an important electrophysiological biomarker, rigid frequency thresholds alone incompletely capture the clinical and electrophysiological spectrum of orthostatic tremor.

The distribution of orthostatic tremor (OT) frequencies across associated neurological and systemic conditions demonstrates substantial overlap between traditionally defined clinical categories. While Parkinsonian disorders accounted for the largest subgroup, a nearly even split between <13 Hz and ≥13 Hz tremors was observed. The frequency distribution was found to be bimodal, similar to the distribution observed for non-isolated OT. Similarly, essential tremor, cerebellar disorders, and brainstem lesions exhibited wide frequency dispersion with substantial proportions of cases exceeding 13 Hz, further supporting a continuous rather than categorical frequency spectrum. Additionally, hyperthyroid states and musculoskeletal injuries, conditions not inherently neurological in nature, also demonstrated both low and high frequency OT [37, 51, 71, 98, 106]. Collectively, these findings indicate marked phenotypic overlap across diverse groups of disorders associated with OT.

A small number of published cases fell outside the 18 Hz defined range, raising questions about how strictly existing EMG frequency cutoffs should be applied. Patients with tremor frequencies exceeding 18 Hz otherwise resembled patients with primary OT, supporting the notion that the current upper frequency limit may represent an arbitrary boundary. We also observed that the MDS classification forced every ≥13 Hz patient into one of two categories: Primary OT (Isolated) or OT-plus. This creates a classification gap for non-neurological diseases such as hyperthyroidism and musculoskeletal injuries, which are neither isolated (Primary OT) nor qualify as neurological symptoms (OT plus). However, their causal or contributory relationships remain uncertain [37, 106]. The MDS consensus also does not clearly define whether stable neurological sequelae, for example, old polio count as OT-plus [50]. It also does not clarify whether incidental MRI abnormalities should count, or whether unrelated neurological symptoms such as neuropathy secondary to diabetes mellitus qualify as OT-plus, resulting in inconsistent classification [42]. However, we acknowledge that not every neurological comorbidity necessarily has a mechanistic relationship with OT, making it challenging to assign a specific classification category for every possible associated disorder.

Several limitations should be acknowledged. The available evidence is derived largely from case reports and case series, which may disproportionately reflect unusual or atypical presentations rather than commonly encountered cases. Reporting bias/publication bias may therefore influence estimates of frequency distribution and associated clinical features. Cases with subharmonics may also be misrepresented if clinicians regard an 8-Hz component as diagnostically insignificant or if they do not report the full frequency range. A related ambiguity is whether the 16-Hz or 8-Hz component should be regarded as the primary frequency, a question with direct implications for classification. In addition, because frequency ranges were converted to mean values for analysis, within-patient variability may have been reduced.

Our review found that the large majority of published cases could be accommodated within the current MDS classification. However, a small subset demonstrated frequency fluctuations across the 13-Hz boundary or frequencies above 18 Hz, highlighting limitations at the margins of the current frequency-based framework. Although tremor frequency remains an important diagnostic feature of OT, our findings indicate that rigid frequency thresholds alone do not adequately distinguish isolated from non-isolated presentations or account for patients with frequency variability, boundary-spanning frequencies, or frequencies outside the currently accepted range. The substantial overlap in tremor frequencies across diverse neurological and non-neurological conditions further suggests that frequency should be interpreted within its clinical context rather than as the primary determinant of disease subtype.

Supplementary table 1

SL NOAUTHORYEAR OF PUBLICATIONAGESEXFREQUENCY (HZ)ISOLATED/NON-ISOLATEDASSOCIATED CONDITIONMDS CLASSIFICATION
1Tseng et al. [20]202534Male3Non-isolatedButane induced encephalopathy, ParkinsonismPseudo OT
2Swinnen et al. [21]202257Female4–5Isolated-Pseudo OT
3Grobe-Einsler et al. [22]202053Female14–16Isolated-Primary OT
4Verriello et al. [23]202082Male15–16Isolated-Primary OT
77Male15–16Isolated-Primary OT
5Yoshii et al. [24]202062Female5–6Isolated-Pseudo OT
6Yoo et al. [25]202069Female4–6Isolated-Pseudo OT
7Chaithra et al. [26]201972Female15–16Non-isolatedParkinson’s diseaseOT Plus
8Wadhwa et al. [27]201962Female17–18Isolated-Primary OT
9Iovino et al. [28]201923Male10.5Isolated-Pseudo OT
10Santus et al. [29]201973Female17Non-isolatedFrontotemporal dementiaOT Plus
11Mousele et al. [30]201866Male11–12Isolated-Pseudo OT
12Yoo et al. [31]201948Male4–6Non-isolatedParkinson’s diseasePseudo OT
13Wuehr et al. [32]201862Male14.5Isolated-Primary OT
55Female14Isolated-Primary OT
75Male17.5Isolated-Primary OT
75Male14Isolated-Primary OT
56Female17Isolated-Primary OT
75Female16.5Isolated-Primary OT
66Female14Isolated-Primary OT
75Male13.5Isolated-Primary OT
76Male15Isolated-Primary OT
14Evidente et al. [33]201873Male10–14Isolated-Unclassifiable(fluctuating)
68Male5–12Non-isolatedEssential TremorPseudo OT
15Shirai et al. [34]201860Male4–5Non-isolatedMachado-Joseph diseasePseudo OT
16Ruiz-Julián et al. [35]201875Female14Isolated-Primary OT
17Lehn et al. [36]201768Male16Isolated-Primary OT
18Larrosa Campo et al. [37]201981Male14–16Non-isolatedThyrotoxicosisPrimary OT
19Chiang et al. [38]201774Female~16Isolated-Primary OT
73Male~16Isolated-Primary OT
20Vidailhet et al. [39]201746Female17Isolated-Primary OT
21Schöberl et al. [40]201756Female17.2Isolated-Primary OT
64Female16Isolated-Primary OT
72Male14Isolated-Primary OT
73Male16.7Isolated-Primary OT
68Female15.5Isolated-Primary OT
74Male14.2Isolated-Primary OT
73Male13.5Isolated-Primary OT
73Female16.5Isolated-Primary OT
73Male14.5Isolated-Primary OT
73Female14.2Isolated-Primary OT
22Benito-Léon et al. [41]201674Female16–18Isolated-Primary OT
64Female10–12Isolated-Pseudo OT
57Male16–18Isolated-Primary OT
68Female16–18Non-isolatedParkinson’s diseaseOT Plus
78Female16–18Non-isolatedParkinson’s diseaseOT Plus
62Female12–16Isolated-Unclassifiable(fluctuating)
37Female16–18Isolated-Primary OT
76Female12–16Isolated-Unclassifiable(fluctuating)
75Female12–16Non-isolatedParkinson’s diseaseUnclassifiable(fluctuating)
77Female12–16Non-isolatedParkinson’s diseaseUnclassifiable(fluctuating)
38Male16–18Isolated-Primary OT
81Female12–16Non-isolatedParkinson’s diseaseUnclassifiable(fluctuating)
65Female16–18Isolated-Primary OT
57Female16–18Isolated-Primary OT
23Blahak et al. [42]201658Female15Non-isolatedDiabetic neuropathyPrimary OT
72Male14Isolated-Primary OT
73Female17Isolated-Primary OT
67Male17Isolated-Primary OT
24Coleman et al. [43]201661Female14Isolated-Primary OT
74Female13–18Isolated-Primary OT
25Athauda et al. [44]201746Female16Isolated-Primary OT
73Male16Isolated-Primary OT
66Male17Non-isolatedParkinsonismOT Plus
26Contarino et al. [45]201570Female16Isolated-Primary OT
27Erro et al. [46]201463Female15Non-isolatedHereditary spastic paraparesisOT Plus
28Mazzucchi et al. [47]201470Female8Non-isolatedGraves’ diseasePseudo OT
29Adebayo et al. [48]201457Female16Isolated-Primary OT
30Vetrugno et al. [49]201377Female16Non-isolatedStiff Person SyndromeOT Plus
55Female16Non-isolatedStiff Person SyndromeOT Plus
31Bhattacharyya et al. [50]201312Male15–16Non-isolatedPoliomyelitisPrimary OT
7Male14–15Non-isolatedEssential tremorOT Plus
32Coffeng et al. [17]201386Male10–11Isolated-Pseudo OT
33Lin et al. [51]201326Male8–9Non-isolatedGraves’ diseasePseudo OT
34Lyons et al. [52]201275Male13Isolated-Primary OT
35Virmani et al. [53]201279Male13.5Isolated-Primary OT
75Female13.3Isolated-Primary OT
36Lee et al. [54]201264Male11–13Non-isolatedSpinal SchwannomaUnclassifiable(fluctuating)
37Lee et al. [55]201181Female4–9Non-isolatedParkinson’s diseasePseudo OT
38Kumar et al. [56]201160Male16Isolated-Primary OT
39Hegde et al. [57]201169Male3–4Isolated-Pseudo OT
40Yaltho et al. [58]201178Male14Isolated-Primary OT
41Magariños-Ascone et al. [59]201068Female12–18Isolated-Unclassifiable(fluctuating)
42Williams et al. [60]201070Female9Non-isolatedCerebellar atrophyPseudo OT
43Vetrugno et al. [61]201058Female16Non-isolatedLeft midbrain lesionOT Plus
44Raudino et al. [62]200959Male13–14Isolated-Primary OT
45Baker et al. [63]200938Female8–15Non-isolatedMultiple SclerosisUnclassifiable(fluctuating)
46Kang et al. [64]200961Female6Non-isolatedParkinson’s diseasePseudo OT
60Female6–7Non-isolatedParkinson’s diseasePseudo OT
61Female4–5Non-isolatedParkinson’s diseasePseudo OT
45Female3–4Non-isolatedParkinson’s diseasePseudo OT
47Female16–17Non-isolatedParkinson’s diseaseOT Plus
47Ramtahal et al. [65]200878Male13–14Isolated-Primary OT
65Male15–16Isolated-Primary OT
65Female15Isolated-Primary OT
48Wegner et al. [66]200861Male16–18Isolated-Primary OT
61Female16–18Isolated-Primary OT
49Espay et al. [67]200873Female15Isolated-Primary OT
67Female15Isolated-Primary OT
50Guridi et al. [68]200855Female16Isolated-Primary OT
51Trocello et al. [69]200849Male16Isolated-Primary OT
76Female17Isolated-Primary OT
55Female17Isolated-Primary OT
66Male16Isolated-Primary OT
66Female15Isolated-Primary OT
49Female15Isolated-Primary OT
75Female16Isolated-Primary OT
62Female16Isolated-Primary OT
74Female16Isolated-Primary OT
78Female17Isolated-Primary OT
70Female18Isolated-Primary OT
70Male15Isolated-Primary OT
52Stich et al. [70]200957Female17.5Non-isolatedDemyelinating lesion involving the right brainstem, Biclonal gammopathy of undetermined significanceOT Plus
53Tan et al. [71]200850Female14–16Non-isolatedGraves’ diseasePrimary OT
54Leu-Semenescu et al. [72]200772Female18Non-isolatedParkinson’s diseaseOT Plus
77Female16Non-isolatedParkinson’s diseaseOT Plus
79Male13.5Non-isolatedParkinson’s diseaseOT Plus
75Female17Non-isolatedParkinson’s diseaseOT Plus
76Female7.5–9Non-isolatedParkinson’s diseasePseudo OT
85Female5Non-isolatedParkinson’s diseasePseudo OT
57Female5–6Non-isolatedParkinson’s diseasePseudo OT
54Female4.3–5Non-isolatedParkinson’s diseasePseudo OT
55Fischer et al. [73]200769Male16–17Isolated-Primary OT
68Male16–17Isolated-Primary OT
63Male16–17Isolated-Primary OT
56Thomas et al. [10]200747Female6–7Non-isolatedParkinsonismPseudo OT
52Male6–7Non-isolatedParkinsonismPseudo OT
52Male6–7Non-isolatedParkinsonism, Kearns-Sayre syndromePseudo OT
26Female6–7Non-isolatedParkinsonismPseudo OT
57de Bie et al. [74]200767Female16–17Non-isolatedProgressive supranuclear palsyOT Plus
58Krauss et al. [75]200658Female15–16Isolated-Primary OT
72Male14Isolated-Primary OT
59Contarino et al. [76]200668Male13Isolated-Primary OT
68Male13Isolated-Primary OT
60Gilhuis et al. [77]200555Female3–5Non-isolatedSmall cell carcinoma of lungPseudo OT
61Karlberg et al. [78]200546Female12Isolated-Pseudo OT
36Male8.5Isolated-Pseudo OT
63Female12.5Isolated-Pseudo OT
64Female15.5Isolated-Primary OT
73Female18Isolated-Primary OT
62Bacsi et al. [79]200559Female15.9Isolated-Primary OT
73Male17.3Isolated-Primary OT
50Female15.2Isolated-Primary OT
57Female16.5Isolated-Primary OT
64Female18.1Isolated-Unclassifiable(>18 Hz)
68Female17.3Isolated-Primary OT
51Female17.3Isolated-Primary OT
69Female16.8Isolated-Primary OT
75Female15.6Isolated-Primary OT
66Male15.7Isolated-Primary OT
63Rodrigues et al. [12]200568Female19Isolated-Unclassifiable(>18 Hz)
70Female14Isolated-Primary OT
74Female16Isolated-Primary OT
53Male15Isolated-Primary OT
63Female14Isolated-Primary OT
65Female13Isolated-Primary OT
64Trip et al. [80]200343Female16Isolated-Primary OT
65Apartis et al. [81]200175Female18Non-isolatedParkinson’s diseaseOT Plus
66Finkel et al. [13]200076Male18–19Isolated-Unclassifiable(>18 Hz)
67Cavallazi et al. [14]200042Female16Isolated-Primary OT
41Male20Isolated-Unclassifiable(>18 Hz)
59Female17Isolated-Primary OT
48Female15Isolated-Primary OT
68Benito-Leon et al. [82]200068Male15Non-isolatedB12 deficiencyOT Plus
69Manto et al. [83]199949Male14Non-isolatedPancerebellar atrophyOT Plus
62Female15Non-isolatedPancerebellar atrophyOT Plus
64Female14Non-isolatedPancerebellar atrophyOT Plus
70Wills et al. [84]199974Male14.5Non-isolatedParkinson’s diseaseOT Plus
71Sander et al. [85]199879Female15–17Isolated-Primary OT
64Male15–17Isolated-Primary OT
72Setta F et al. [86]199848Male14Non-isolatedCerebellar atrophyOT Plus
63Female14Non-isolatedCerebellar atrophyOT Plus
61Female15Non-isolatedCerebellar atrophyOT Plus
73Tsai et al. [87]199858Female16Isolated-Primary OT
68Female16Isolated-Primary OT
74Benito-Leon et al. [88]199749Female7–8Non-isolatedRight pontine lesionPseudo OT
39Male14–15Non-isolatedLeft pontine lesionOT Plus
75Hanna et al. [89]199733Female17.5Isolated-Primary OT
76Poersch et al. [90]199460Female14Isolated-Primary OT
77Britton et al. [91]199263Female16–18Isolated-Primary OT
25Female8–16Isolated-Unclassifiable(fluctuating)
68Male16–17Isolated-Primary OT
57Female15–16Isolated-Primary OT
47Female16–18Isolated-Primary OT
64Male15–16Isolated-Primary OT
78Willeit et al. [92]199177Male14–16Isolated-Primary OT
57Male14–16Isolated-Primary OT
79FitzGerald et al. [15]199160Male18–20Non-isolatedEssential tremorUnclassifiable(>18 Hz)
46Male12–14Non-isolatedEssential tremorUnclassifiable(fluctuating)
70Male12Non-isolatedEssential tremorPseudo OT
56Female14Non-isolatedEssential tremorOT Plus
80Walker et al. [93]199079Male15Isolated-Primary OT
81Gabellini et al. [94]199068Female14–16Isolated-Primary OT
56Female14–16Isolated-Primary OT
45Female14–16Isolated-Primary OT
75Female6–7Isolated-Pseudo OT
64Male6–7Isolated-Pseudo OT
66Male6–7Isolated-Pseudo OT
59Male6–7Non-isolatedAqueduct stenosis hydrocephalusPseudo OT
47Female6–7Non-isolatedChronic relapsing radiculopathyPseudo OT
82Oda et al. [95]198979Female4Non-isolatedVascular ParkinsonismPseudo OT
83Uncini et al. [96]198973Male8–10Isolated-Pseudo OT
64Female16Isolated-Primary OT
84Papa et al. [97]198863Female16Non-isolatedEssential tremorOT Plus
72Female16Non-isolatedEssential tremorOT Plus
68Female16Non-isolatedEssential tremorOT Plus
85Thompson et al. [9]198655Male8–16Isolated-Unclassifiable(fluctuating)
86Kim et al. [98]202318Male5–6Non-isolatedKnee contusionPseudo OT
87Park et al. [99]202079Female4–4.5Non-isolatedRight pontine lesionPseudo OT
78Female6.5Non-isolatedParkinsonismPseudo OT
74Female8Non-isolatedBrain lesionPseudo OT
46Female9Non-isolatedParkinson’s diseasePseudo OT
63Male13.5–14Non-isolatedRestless leg syndromeOT Plus
62Female6Non-isolatedDrug induced parkinsonismPseudo OT
59Male5–6Non-isolatedTardive dyskinesiaPseudo OT
68Female15Isolated-Primary OT
49Male4–5Non-isolatedArteriovenous malformationPseudo OT
65Female4Non-isolatedREM sleep behaviour disorderPseudo OT
67Male8–8.5Non-isolatedParkinsonism with Normal Pressure hydrocephalusPseudo OT
58Female16Isolated-Primary OT
72Male13Non-isolatedDementiaOT Plus
61Male13Isolated-Primary OT
56Female13Isolated-Primary OT
72Male8Non-isolatedParkinson’s disease with Essential TremorPseudo OT
68Male6–7Non-isolatedEssential tremorPseudo OT
65Female4–4.5Non-isolatedParkinson’s diseasePseudo OT
88Comolli et al. [100]202465Female6Non-isolatedGraves’ diseasePseudo OT
89Li et al. [101]202222Male6–8Non-isolatedHyperphenylalaninemiaPseudo OT
90Lv et al. [102]202267Male16Non-isolatedPrimary malignant melanoma of the spinal cordOT Plus
91Bhattacharyya et al. [103]200370Male18Isolated-Primary OT
92Jones et al. [104]201165Male16Isolated-Primary OT
93Manrique-Huarte et al. [105]201265Female14–16Isolated-Primary OT
69Female2–9Non-isolatedPsychogenic dizzinessPseudo OT
45Female10Isolated-Pseudo OT
63Female8Non-isolatedMigraine with auraPseudo OT
94Yague et al. [106]201147Female16Non-isolatedSurgery to left meniscus following traumaPrimary OT
95Sanitate et al. [107]199372Female14–15Non-isolatedHead trauma, demyelinating lesions in the periventricular region and subcortical white matter, Ischemic changesin the right pons and the right cerebellar hemisphereOT Plus
96Marechal et al. [108]202473Male14Non-isolatedRestless leg syndrome, PSPOT Plus
97Myers et al. [109]200372Female16Isolated-Primary OT
98Sarva et al. [110]201681Male13.8–15.9Non-isolatedCerebellar degenerationOT Plus
57Male13Non-isolatedSpinocerebellar ataxiaOT Plus
99Picillo et al. [111]201774Female18Non-isolatedHereditary spastic paraplegia (SPG31)OT Plus
30Female9Non-isolatedHereditary spastic paraplegia (SPG15)Pseudo OT
100Brotman et al. [112]200065Male3–4Non-isolatedNeurosyphillisPseudo OT

Data Accessibility Statement

The datasets generated and analyzed during the current study are available from the corresponding author on reasonable request.

Author Contributions

Leroy D’Souza: Conceptualization, Data curation, Formal analysis, Methodology, Writing – review and editing.

Niharika B R: Data curation, Formal analysis, Writing – original draft.

Julián Benito-León: Supervision, Writing – review and editing.

Samarth B R: Data curation, Formal analysis, Writing – original draft.

Rishika Das: Data curation, Formal analysis, Writing – original draft.

Muskan Kotwal: Data curation, Formal analysis, Writing – original draft.

Kruthika Reddy: Data curation, Formal analysis, Writing – original draft.

Pranav Anil Katti: Data curation, Formal analysis, Writing – original draft.

C S Pranav Bhat: Formal analysis, Writing – original draft.

DOI: https://doi.org/10.5334/tohm.1278 | Journal eISSN: 2160-8288
Language: English
Page range: 55 - 55
Submitted on: Aug 5, 2026
Accepted on: Sep 26, 2026
Published on: Oct 8, 2026
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services

© 2026 Leroy D’Souza, Niharika B. R., Julián Benito-León, Samarth B. R., Rishika Das, Muskan Kotwal, Kruthika Reddy, Pranav Anil Katti, C. S. Pranav Bhat, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.